Natural Products in Cancer Therapy: Past, Present and Future
2021 · Natural Products and Bioprospecting · 592 citations
https://doi.org/10.1007/s13659-020-00293-7
M
Min Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
366
Papers
11.7K
Citations
56
h-index
190
i10-index
Min Huang is an academic researcher from BGI Group (China). The author has contributed to research in topics: DNA Repair Mechanisms & Peptidase Inhibition and Analysis & Cancer, Hypoxia, and Metabolism. The author has an h-index of 56, co-authored 312 publications.
ORCID: 0000-0001-6735-1612Papers by this author
worksChemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation
2017 · Cell Research · 183 citations
https://doi.org/10.1038/cr.2017.54
circHECTD1 facilitates glutaminolysis to promote gastric cancer progression by targeting miR-1256 and activating β-catenin/c-Myc signaling
2019 · Cell Death and Disease · 138 citations
https://doi.org/10.1038/s41419-019-1814-8
Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer
2017 · Nature Communications · 99 citations
https://doi.org/10.1038/ncomms14929
The Role of Polymeric Immunoglobulin Receptor in Inflammation-Induced Tumor Metastasis of Human Hepatocellular Carcinoma
2011 · JNCI Journal of the National Cancer Institute · 82 citations
https://doi.org/10.1093/jnci/djr360
Topotecan Is a Substrate for Multidrug Resistance Associated Protein 4
2005 · Current Drug Metabolism · 74 citations
https://doi.org/10.2174/138920006774832550
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat